Physician profile
Divya Ramani
NPI 1730867243
$1,444.81
in general payments reported to CMS, 2019-2025
14 companies · $1,445 in 2025
The $1,445 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,444.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $300.66 | 2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.28 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $215.03 | 2025 | |
| Stryker Corporation | $168.73 | 2025 | Aequalis Ascend Flex |
| Pfizer INC. | $143.69 | 2025 | |
| Lilly USA, LLC | $87.25 | 2025 | Jardiance, Zepbound, Mounjaro |
| Sanofi-Aventis U.S. LLC | $66.57 | 2025 | |
| Exact Sciences Corporation | $59.41 | 2025 | The Cologuard Plus Collection Kit |
| Dexcom, INC. | $46.89 | 2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $39.37 | 2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $17.28 | 2025 | Airsupra |
| Medtronic, INC. | $16.75 | 2025 | Venaseal |
| Viiv Healthcare Company | $15.72 | 2025 | Apretude |
| Cleerly, INC. | $14.18 | 2025 | Cleerly Ischemia, Cleerly Labs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divya Ramani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.